Respiratory medication use in an Australian developmental disability clinic population: messages for health care professionals

Sharon R. Davis, Seeta Durvasula, Diana Merhi, Paul M. Young, Daniela Traini, Sinthia Z. Bosnic-Anticevich

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Australian data suggest up to 15% of people with intellectual disability (ID) have asthma. The inhaled route of administration is optimal for the management of obstructive airways diseases; however, correct inhaler use requires dexterity and particular breathing patterns and potentially represents a problem in this population due to physical and cognitive deficits. Understanding the nature and extent of inhaler use in persons with ID is important, as correct inhaler technique is imperative for optimal clinical outcomes; however, currently no evidence base exists to inform health professionals. This study describes respiratory medication use, reported prevalence of asthma, and asthma management practices undertaken in a clinic sample of Australian adults with ID. Results showed a prevalence of retrospectively reported asthma of 6%, with 86% of asthma patients prescribed inhaled medication. A review of patient records also indicated omission of some recommended asthma management strategies.
Original languageEnglish
Pages (from-to)278-284
Number of pages7
JournalAustralian Journal of Primary Health
Volume20
Issue number3
DOIs
Publication statusPublished - 2014
Externally publishedYes

Keywords

  • asthma
  • caregivers
  • inhalers (pMDI and DPI)
  • inhaler technique
  • nebulisers

Fingerprint

Dive into the research topics of 'Respiratory medication use in an Australian developmental disability clinic population: messages for health care professionals'. Together they form a unique fingerprint.

Cite this